Improving Health and Wellbeing for People Diagnosed With Chronic Spontaneous Urticaria (CSU)

Sponsor
Royal College of Surgeons, Ireland (Other)
Overall Status
Suspended
CT.gov ID
NCT06108869
Collaborator
(none)
100
1
20
49
2

Study Details

Study Description

Brief Summary

This study aims to investigate the influence of psychosocial factors on Chronic Spontaneous Urticaria (CSU). Preliminary research suggests a potential link between stress and the experience of CSU symptoms. In light of these findings, our study offers a stress management intervention for individuals diagnosed with CSU.

The intervention consists of a 6-week online course designed to cultivate effective stress management techniques, referred to as 'attention-based training (ABT).' The course asks each participant to develop their own ABT practice, along with a one-hour session per week, providing techniques that participants can use to combat stressors related to their condition.

Condition or Disease Intervention/Treatment Phase
  • Other: ABT Online Programme
  • Other: Delayed Control group
N/A

Detailed Description

Chronic Spontaneous Urticaria (CSU) is a common disorder that is poorly understood and frequently misdiagnosed. The burden of the disease can include stress, anxiety, sleep disturbances, and difficulty with activities of daily living. Furthermore, psychological difficulties such as stress, may also aggravate the symptomatic burden of CSU. Holistic interventions are used as a complementary approach to alleviate symptoms in chronic diseases and may represent a valuable non-pharmacological approach in CSU. In 2021, Dr Padraic Dunne and colleagues published a feasibility assessment of an 8 week attention-based training programme to aid in the management of CSU [1]. Whilst this trial was deemed feasible and valuable for participants involved, further research was required with a wider sample to determine the role ABT may have in the management of the condition.

List of Aims and Objectives This current research aims to expand on their pilot study, and provide an evidence based non-pharmacological intervention to aid those in their management of CSU. This project will be the one of the first to provide CSU patients with a psychological intervention in conjunction with their clinical treatment. We believe that a combination of non-pharmacological and pharmacological solutions will ease the suffering caused by this condition and reduce the physical and fiscal burden on the Irish Health service and related clinics.

This study will 1.) Aim to identify the current psychosocial baseline of CSU patients attending urticarial clinics in Ireland and Scotland, to further highlight the psychosocial experience of this population. 2.) Provide and assess the effectiveness of an 6 week ABT programme for CSU management and patient wellbeing.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Single groups will be taken through the ABT programme, or the delayed control interventionSingle groups will be taken through the ABT programme, or the delayed control intervention
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Improving Health and Wellbeing for People Diagnosed With Chronic Spontaneous Urticaria (CSU)
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2026
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

6 Week ABT intervention as described.

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 2

6 Week ABT intervention as described.

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 3

6 Week ABT intervention as described.

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 4

6 Week ABT intervention as described.

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 5

6 Week ABT intervention as described.

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Active Comparator: 6

Delayed intervention group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 7

Delayed intervention group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 8

Delayed intervention group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 9

Delayed intervention group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 10

Delayed intervention group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Experimental: 11

ABT intervention as described

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 12

ABT intervention as described

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 13

ABT intervention as described

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 14

ABT intervention as described

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Experimental: 15

ABT intervention as described

Other: ABT Online Programme
When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: A short ABT practice An educational component related to the development of our ABT practice A group discussion on the week's topic and how it relates to you and your diagnosis

Active Comparator: 16

Delayed Control group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 17

Delayed Control group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 18

Delayed Control group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 19

Delayed Control group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Active Comparator: 20

Delayed Control group

Other: Delayed Control group
Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

Outcome Measures

Primary Outcome Measures

  1. Identify Psychosocial Baseline of CSU patents attending Urticaria clinics [21 months from month 8]

    Identify the incidence of abnormal stress/wellbeing scores of CSU patients attending urticarial clinics in Ireland and Scotland, using a baseline questionnaire made up of the Short Stress Overload Scale (10 questions), Five Facet Mindfulness Questionnaire (FFMQ) (39 questions), PERMA Profiler for wellbeing (23 questions), The Urticaria Control Test (4 questions) and Dermatology Life Quality Index (10 questions).

  2. Assess change in psychosocial measures of participants after completing an online 6 week ABT programme [21 months from month 8]

    A psychosocial questionnaire made up of the Short Stress Overload Scale (10 questions), Five Facet Mindfulness Questionnaire (FFMQ) (39 questions), PERMA Profiler for wellbeing (23 questions), The Urticaria Control Test (4 questions) and Dermatology Life Quality Index (10 questions) will be provided to patients pre and post participation in the 6 week online ABT intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must have diagnosis of CSU
Exclusion Criteria:
  • Classified as a vulnerable adult Cannot communicate online, in English

Contacts and Locations

Locations

Site City State Country Postal Code
1 St James's Hospital Dublin Ireland

Sponsors and Collaborators

  • Royal College of Surgeons, Ireland

Investigators

  • Principal Investigator: Niall Conlon, PhD, St. James's Hospital, Ireland

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Royal College of Surgeons, Ireland
ClinicalTrials.gov Identifier:
NCT06108869
Other Study ID Numbers:
  • 23-151
First Posted:
Oct 31, 2023
Last Update Posted:
Oct 31, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 31, 2023